Clinical Trial

Evaluation of Remote Photoplethysmography to Assist Vital Signs Measure in Pediatrics

Study acronym: rMonitoped1
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 28, 2026 (before its estimated July 2, 2026 completion). Its status may not reflect the trial's current state.
Summary
Introduced in 1930, photoplethysmography techniques presented the possibility of measuring SpO2 and heart rates (HR) using the absorption of light by the blood to define these signals. In recent years, a new approach to photoplethysmography to measure physiological parameters without contact has been developed. This technique, called remote Photoplethysmography Imaging (rPPG), uses the different Red - Green - Blue color spectra at a skin captured by the camera video to determine a plethysmography signal. However, it has never been studied in pediatric patients. The objective is to evaluate the remote photoplethysmography technology to measure vital signs in pediatrics
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-26; most recent amendment 2026-01-26.
Status change: Not Yet Recruiting → Recruiting 2025-07-07
Trial Details
NCT Number NCT06231654
Lead Sponsor Fondation Lenval
Conditions Using Remote Photoplethysmography for Physiological Parameters
Enrollment 600 participants
Start Date 2025-07-02
Primary Completion 2026-07-02 (estimated)
Study Completion 2026-07-02 (estimated)
Updated on ClinicalTrials.gov 2026-01-28